SPO Medical to Conduct Live Investor Meeting on April 29, 2008

Using WallStreet VIPs' New Platform to Reach Wide Investor Audience
SPO Medical Inc. (SPOM), a leading developer of biosensor and
microprocessor technologies for use in portable monitoring devices, announced
today that it will be delivering a live, virtual investor presentation, using
WallStreet VIPs' new platform on April 29, 2008 at 1 PM Eastern Daylight Time
(EDT).
NEW YORK, April 10 /PRNewswire-FirstCall/ -- "SPO Medical is a company on
the move, though many investors still are not familiar with us," said Michael
Braunold, President and Chief Executive Officer of SPO Medical. "We just
reported our 2007 full year results with record sales; we added two new
professional products, the finger PulseOx 6000(TM) and the hand-held PulseOx
6100(TM), and increased our network of distributors to 38 countries. Using
WallStreet VIPs, we disseminate our story to the investor community
broadcasting directly on the internet. It's a very effective way to reach out
to the broader investor community, since presenters and investors can meet
easily and conveniently from their respective offices."
"WallStreet VIPs is a 21st century productivity solution to the
challenges of scheduling quality time for live meetings and provide great
value added for every public company's comprehensive Investor Relations
strategy in today's global village and permanent time constraints," stated
Jerry Cahn, Ph.D., J.D., President of WallStreet VIPs. "Investor meetings are
the life-blood of public companies. They enable the companies to maintain
contact with the investor community educating and updating them on the
company's business strategy and developments. CEOs traditionally engage in
road shows traveling from city-to-city to meet investors impacting their time
and attention that should be devoted to running their businesses."
For a free invitation to SPO Medical's virtual meeting, please register
at http://www.WallStreetVIPs.com
About SPO Medical
SPO Medical (SPOM) a leading developer of biosensor and microprocessor
technologies for use in portable monitoring devices to capture life-saving
and life-enhancing information within four key markets: medical care; home
and remote-care; sports and wellness; and safety and security. Its patented
technology uses information gathered from the reflectance of light on the
human blood stream, in a non-invasive manner, to monitor key vital signs. The
Company distributes its products through a network of distributors and also
licenses its technologies to appropriate client corporations for
commercialization and distribution. For more information, visit
http://www.spomedical.com.
About Wall Street VIPs
WallStreet VIPs is the 21st century productivity solution to the
challenges of scheduling quality time, live meetings with potential and
existing investors. When integrated with face-to-face meetings for the most
serious investors making commitments, VIPs become a key part of every
company's comprehensive investor relations strategy. WallStreet VIPs
coordinates the whole program, scheduling the event, inviting qualified
investors, coaching the presenter on using the platform, helping make the
investor presentation compelling and providing details on the attending
audience. For details, see: http://www.WallStreetVIPs.com.
Safe Harbor:
This press release contains forward-looking statements that involve
substantial uncertainties and risks. These forward-looking statements are
based upon our current expectations, estimates and projections about our
business and our industry, and that reflect our beliefs and assumptions based
upon information available to us at the date of this release. We caution
readers that forward-looking statements are predictions based on our current
expectations about future events. These forward-looking statements are not
guarantees of future performance and are subject to risks, uncertainties and
assumptions that are difficult to predict. Our actual results, performance or
achievements could differ materially from those expressed or implied by the
forward-looking statements as a result of a number of factors, including but
not limited to, changes in economic conditions generally and the medical
devices market specifically, changes in technology, legislative or regulatory
changes that affect us, the availability of working capital, the introduction
of competing products, market acceptance of our new products, changes in our
operating strategy or development plans and the risks and uncertainties
discussed under the heading "Risk Factors" in Item 1 of our Annual Report on
Form 10-KSB for the fiscal year ended December 31, 2007. We undertake no
obligation to revise or update any forward-looking statement for any reason.
Investor Contacts

SPO Medical: Target 3 Communications:
Michael Braunold, President & CEO Eugene Feyman, Director
info@spomedical.com eugene@target3.com
+1-805-823-8163 +1-646-827-0009

SOURCE SPO Medical Inc.

Investor Contacts: SPO Medical: Michael Braunold, President & CEO,
info@spomedical.com, +1-805-823-8163; Target 3 Communications: Eugene Feyman,
Director, eugene@target3.com, +1-646-827-0009